Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Korro Bio (KRRO) Non-Current Debt (2019 - 2022)

Korro Bio's Non-Current Debt history spans 4 years, with the latest figure at $4.2 million for Q4 2022.

  • For the quarter ending Q4 2022, Non-Current Debt fell 70.59% year-over-year to $4.2 million, compared with a TTM value of $4.2 million through Dec 2022, down 70.59%, and an annual FY2022 reading of $4.2 million, down 70.59% over the prior year.
  • Non-Current Debt for Q4 2022 was $4.2 million at Korro Bio, down from $6.7 million in the prior quarter.
  • The five-year high for Non-Current Debt was $15.0 million in Q4 2020, with the low at $180000.0 in Q4 2019.
  • Average Non-Current Debt over 4 years is $9.7 million, with a median of $11.7 million recorded in 2022.
  • Year-over-year, Non-Current Debt soared 8233.33% in 2020 and then crashed 70.59% in 2022.
  • Tracing KRRO's Non-Current Debt over 4 years: stood at $180000.0 in 2019, then soared by 8233.33% to $15.0 million in 2020, then fell by 5.55% to $14.2 million in 2021, then plummeted by 70.59% to $4.2 million in 2022.
  • Per Business Quant, the three most recent readings for KRRO's Non-Current Debt are $4.2 million (Q4 2022), $6.7 million (Q3 2022), and $9.2 million (Q2 2022).